Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 3 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 6Melanoma 4Skin Neoplasms 2Neoplasm Metastasis 2Carcinoma, Squamous Cell 2Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Recurrence 1Kidney Neoplasms 1Eyelid Squamous Cell Carcinoma 1Cutaneous Squamous Cell Carcinoma 1Colorectal Neoplasms 1Cholangiocarcinoma 1Carcinoma, Merkel Cell 1Carcinoma, Large Cell 1Carcinoma, Hepatocellular 1Brain Neoplasms 1Anus Neoplasms 1Adenocarcinoma 1

Interventions

Oxaliplatin 10Fluorouracil 7Leucovorin 6Gemcitabine 6Docetaxel 6Capecitabine 6Paclitaxel 5Cisplatin 5zolbetuximab 4Ramucirumab 3Pemetrexed 3Drug Therapy 3Carboplatin 3Albumin-Bound Paclitaxel 3130-nm albumin-bound paclitaxel 3regorafenib 2pembrolizumab 2Vinorelbine 2Surgical Procedures, Operative 2Radiotherapy 2Nivolumab 2Neoadjuvant Therapy 2Cyclophosphamide 2Chemoradiotherapy 2Bevacizumab 2Afatinib 2vandetanib 1trifluridine tipiracil drug combination 1trastuzumab deruxtecan 1tislelizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Adenocarcinoma × cemiplimab × Clear all
NCT06908304 2026-01-12

A Phase III Study With THIO + Cemiplimab vs Chemotherapy as 3rd Line Treatment in Advanced/Metastatic NSCLC

Maia Biotechnology

Phase 3 Recruiting
300 enrolled
Thoracic

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Carcinoma, Large Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡